Equity Capital Markets

Company · CIK 1808805

Nautilus Biotechnology, Inc.

CIK1808805 (SEC EDGAR)
Industry (SIC)3826 — Laboratory Analytical Instruments
Business addressWA
ListedNAUT (Nasdaq)
First annual or quarterly report2020-09-18

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-277437
ShelfEffective
 2024-02-282026-09-184
333-298884
ShelfEffective
 2026-09-112026-09-182
333-258100
Registered companyEffective
 2021-07-222022-08-084
333-239986
IPOFinal prospectus
 2020-07-212020-08-104

Filings

17
FiledFilingRegistrationAccession
2026-09-18EFFECTDeclared effective 333-2988849999999995-26-003012
2026-09-18424B5Shelf takedown 333-2774370001808805-26-000047
2026-09-11S-3Shelf registered 333-2988840001808805-26-000040
2024-03-06EFFECTDeclared effective 333-2774379999999995-24-000612
2024-03-06424B5Shelf takedown 333-2774370001628280-24-009428
2024-02-28S-3Shelf registered 333-2774370001628280-24-007392
2022-08-08EFFECTDeclared effective 333-2581009999999995-22-002288
2022-03-01EFFECTDeclared effective 333-2581009999999995-22-000531
2021-08-06EFFECTDeclared effective 333-2581009999999995-21-003091
2021-07-22S-1Registration filed 333-2581000001628280-21-014270
2021-05-13EFFECTDeclared effective 333-2547969999999995-21-001918
2021-02-16DRSDraft made public 377-042330001628279-21-000107
2020-08-10424B4Final prospectus 333-2399860001140361-20-018021
2020-08-06EFFECTDeclared effective 333-2399869999999995-20-002057
2020-07-30S-1/AAmendment 333-2399860001140361-20-016987
2020-07-21S-1Registration filed 333-2399860001140361-20-016469
2020-04-17DRSDraft made public 377-031300001140361-20-009126

All filings of this company · CSV